13F Pro quality score
Rank #2,297 of 2,925
Rankings refresh quarterly once 80% of peers have filed. Next update: ~Nov 14, 2026.
Reported revenue, net income and operating margin by fiscal year, from Intercure Ltd.'s annual filings on SEC EDGAR.
| Period | Form | Revenue | Net income | Op. marginOperating margin |
|---|---|---|---|---|
| FY 2025 | 20-F | $270.2M | $-35.7M | -10.1% |
| FY 2024 | 20-F | $238.8M | $-67.8M | -28.1% |
| FY 2023 | 20-F | $355.6M | $-62.0M | -11.7% |
| FY 2022 | 20-F | $388.7M | $44.8M | 13.0% |
| FY 2021 | 20-F | $219.7M | $4.7M | 12.8% |
| FY 2020 | 20-F | $65.0M | $-37.2M | -59.1% |
Ranked by quality-factor profile and overlapping institutional ownership, from the latest 13F filings and SEC financials.
Officers, directors and 10% owners with a Form 4 filed in the last 24 months, most recent first. From SEC EDGAR.
Intercure Ltd. (INCR) stock profile, AI quality score, and SEC EDGAR financial data, a Healthcare sector company. 13F Pro's AI-powered ranking engine scores INCR at 35.4/100 on a composite quality score built from its SEC filings, placing it at rank #2,297 of 2,925 stocks — the bottom half of the AI-ranked universe. Based on the latest XBRL financial filings (FY 2025), Intercure Ltd. reports quarterly revenue of $270.2M, net income of $-35.7M, an operating margin of -10.1%. Top institutional holders of INCR by reported 13-F value include HEALTHCARE OF ONTARIO PENSION PLAN FUND, CITADEL ADVISORS, MOORE CAPITAL MANAGEMENT, based on the most recent SEC filings. INCR trades on the Nasdaq exchange and files with the SEC under CIK 1857030. 13F Pro's AI research platform runs 10 specialized AI analysts — value, growth, momentum, macro, and activist specialists — that debate INCR daily and publish AI-generated analysis with cited SEC sources. The platform aggregates historical XBRL financial facts, 10-Q and 10-K filings, insider Form 4 transactions, and institutional 13-F holdings for Intercure Ltd. directly from SEC EDGAR.